A-CAR032

· Shanghai AbelZeta Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A-CAR032, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Trial of A-CAR032 in Participants With mCRPC [Phase 1]